Who founded Teitur Trophics?

Teitur Trophics was founded by Simon Mølgaard, Anders Dalby, Mathias Ollendorff, Simon Glerup in 2020.

Who are Teitur Trophics's investors?

Teitur Trophics's investors include Industrifonden, P53 Invest, Innovestor, Sound Bioventures, Sunstone Capital.

Where is Teitur Trophics headquartered?

Teitur Trophics is headquartered in Aarhus, DK.

Teitur Trophics

Aarhus, DK · Founded 2020 · 25 employees on LinkedIn · 7 known investors

Find your way into Teitur Trophics

Paths you didn't know you had: your email and LinkedIn already hold routes to the Teitur Trophics team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Teitur Trophics is a biotech company developing therapies that target the sortilin family of receptors (SorCS-receptor biology) to activate the brain's natural survival pathways and preserve brain function. Its approach aims to address multiple neurodegenerative diseases by protecting brain cells from dying.

Biotech Deep Tech Healthtech Longevity

Founders & leadership

Teitur Trophics was founded in 2020 by Simon Mølgaard, Anders Dalby, Mathias Ollendorff, and Simon Glerup.

Simon MølgaardCo-founder & CEO

Anders DalbyCo-founder

Mathias OllendorffCo-founder

Simon GlerupCo-founder

Investors · 7

Industrifonden✓ confirmed by Teitur TrophicsStockholm · $960K – $4.8M

How we know: Industrifonden's portfolio page · the company's own site · funding news · prnewswire.com · open dataset · 5k.vc investor directory · Not right? Tell us

P53 Invest✓ confirmed by Teitur TrophicsStavanger

How we know: P53 Invest's portfolio page · the company's own site · funding news · prnewswire.com · Not right? Tell us

Innovestor✓ confirmed by Teitur TrophicsFinland

How we know: the company's own site · Not right? Tell us

Sound Bioventures✓ confirmed by Teitur TrophicsMalmö

How we know: the company's own site · funding news · prnewswire.com · the VCSheet dataset · Not right? Tell us

Sunstone CapitalreportedFrederiksberg

How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Also in the syndicate · 2

Innovestor's Life Science FundSunstone Life Science Ventureslead

Funding

SEC filings, press & company announcements

Undisclosed amountSeries AMar 2023 · 3 sources
Sound Bioventures (lead), Sunstone Life Science Ventures (lead), Industrifonden, Innovestor's Life Science Fund, P53 Invest
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Teitur Trophics Raises EUR 28M in Series A Financing to Advance the Development and Treatment for Neurodegenerative Diseasesprnewswire.com · Mar 2023

Teitur Trophics Raises EUR 28M in Series A Financingfinsmes.com · Mar 2023

Frequently asked questions

What does Teitur Trophics do?: Teitur Trophics is a biotech company developing therapies that target the sortilin family of receptors (SorCS-receptor biology) to activate the brain's natural survival pathways and preserve brain function. Its approach aims to address multiple neurodegenerative diseases by protecting brain cells from dying.
Who founded Teitur Trophics?: Teitur Trophics was founded by Simon Mølgaard, Anders Dalby, Mathias Ollendorff, Simon Glerup in 2020.
Who are Teitur Trophics's investors?: Teitur Trophics's investors include Industrifonden, P53 Invest, Innovestor, Sound Bioventures, Sunstone Capital.
Where is Teitur Trophics headquartered?: Teitur Trophics is headquartered in Aarhus, DK.